Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
488 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. | completed | Phase 2 | 52 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | completed | Phase 2 | 39 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 |
| clinicaltrials |
| NCT00351039 | Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 8 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00360828 | Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas | terminated | Phase 2 | 10 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00363467 | Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation | terminated | N/A | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00365872 | External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | completed | Phase 2 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00604461 | Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) | terminated | Phase 1 / Phase 2 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | terminated | Phase 2 | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00612677 | Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem | terminated | Phase 2 | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00815685 | A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia | completed | N/A | 36 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT01253148 | Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma | completed | N/A | 25 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT03077113 | Pilot Study of Regional Lung Ventilation | completed | N/A | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT03077126 | Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer | completed | N/A | 10 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT00307086 | Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants | completed | Phase 2 | 30 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT00231465 | Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00361140 | Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | completed | Phase 4 | 72 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01581307 | Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets | completed | Phase 2 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | completed | Phase 1 | 82 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00323206 | Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma | completed | N/A | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00437957 | Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases | terminated | Phase 1 | 10 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00444015 | Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 34 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00740038 | Support for People Undergoing Chemotherapy | completed | N/A | 471 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01198821 | Gem-TABS in Unresectable Pancreatic Carcinoma | completed | Phase 1 | 8 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01302821 | C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT01352000 | Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline") | completed | N/A | 3,830 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01416909 | Managing Medication-induced Constipation in Cancer: A Clinical Trial | completed | N/A | 601 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01434550 | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT01852591 | Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant(PCV13) | completed | N/A | 8 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 2, 2017 | clinicaltrials |
| NCT01841021 | Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 | terminated | N/A | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 19, 2017 | clinicaltrials |
| NCT01422993 | Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy | completed | N/A | 4 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 29, 2016 | clinicaltrials |
| NCT01376453 | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 12, 2016 | clinicaltrials |
| NCT01450046 | Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 7, 2016 | clinicaltrials |
| NCT01951976 | Yoga for Aromatase Inhibitor-associated Joint Pain | completed | N/A | 16 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 4, 2016 | clinicaltrials |
| NCT01269645 | Facts and Attitudes About Clinical Trials(FACT) | completed | N/A | 471 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 8, 2016 | clinicaltrials |
| NCT01347034 | Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) | completed | Phase 2 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT02061007 | Biomarker Correlates of Hypoxia in Metastatic Melanoma | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | May 9, 2016 | clinicaltrials |
| NCT01606345 | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | completed | Phase 1 | 4 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 22, 2016 | clinicaltrials |
| NCT01446952 | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT01683149 | Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 4, 2016 | clinicaltrials |
| NCT00985777 | Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia | completed | Phase 1 | 26 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 1, 2016 | clinicaltrials |
| NCT01822691 | Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS) | completed | Phase 2 | 15 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT02283359 | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus | terminated | Phase 1 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | completed | Phase 1 | 16 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00673738 | Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) | completed | Phase 2 | 27 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT01008527 | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | completed | Phase 1 | 22 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT01419210 | Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer | completed | N/A | 28 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT00609869 | Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab | completed | Phase 2 | 29 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | terminated | Phase 2 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01419613 | Promoting a Healthier Lifestyle Among Breast Cancer Survivors | completed | N/A | 68 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01846429 | Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | terminated | Phase 1 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 4, 2015 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials